{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:20:24Z","timestamp":1776068424264,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["W-1253"],"award-info":[{"award-number":["W-1253"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.06.033","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T13:31:36Z","timestamp":1530192696000},"page":"4672-4680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine"],"prefix":"10.1016","volume":"36","author":[{"given":"Marco","family":"Grasse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Meryk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Miggitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrix","family":"Grubeck-Loebenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2018.06.033_b0005","first-page":"283","article-title":"Diphtheria Toxoid as an Immunising Agent","volume":"4","author":"Glenny","year":"1923","journal-title":"Br J Exp Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.033_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2105\/AJPH.22.1.7","article-title":"Diphtheria toxin-antitoxin and toxoid, a comparison","volume":"22","author":"Park","year":"1932","journal-title":"Am J Pub Health Nation's Health"},{"issue":"47\u201348","key":"10.1016\/j.vaccine.2018.06.033_b0015","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1016\/j.vaccine.2006.06.037","article-title":"Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers","volume":"24","author":"Kaml","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2018.06.033_b0020","doi-asserted-by":"crossref","first-page":"e82967","DOI":"10.1371\/journal.pone.0082967","article-title":"Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons","volume":"8","author":"Weinberger","year":"2013","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.033_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12979-016-0081-0","article-title":"Booster vaccination against tetanus and diphtheria: insufficient protection against diphtheria in young and elderly adults","volume":"13","author":"Grasse","year":"2016","journal-title":"Immunity Ageing: I & A."},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2018.06.033_b0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.vaccine.2003.08.012","article-title":"Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults","volume":"22","author":"van Damme","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.033_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.mej.0000228449.37974.7e","article-title":"Seroprotection against tetanus in patients attending an emergency department in Belgium and evaluation of a bedside immunotest","volume":"14","author":"Stubbe","year":"2007","journal-title":"Eur J Emerg Medi: Off J Eur Soc Emerg Med"},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.033_b0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4161\/hv.5.5.7575","article-title":"Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations","volume":"5","author":"Launay","year":"2009","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2018.06.033_b0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.exger.2017.08.037","article-title":"Protection against Tetanus and Diphtheria in Europe: the impact of age, gender and country of origin based on data from the MARK-AGE study","volume":"105","author":"Weinberger","year":"2018","journal-title":"Exp Gerontol"},{"issue":"9","key":"10.1016\/j.vaccine.2018.06.033_b0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0264-410X(96)00021-7","article-title":"Immunization against diphtheria with special emphasis on immunization of adults","volume":"14","author":"Galazka","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.033_b0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1699-0463.1986.tb02114.x","article-title":"Revaccination of adults against diphtheria. I: responses and reactions to different doses of diphtheria toxoid in 30\u201370-year-old persons with low serum antitoxin levels","volume":"94","author":"Simonsen","year":"1986","journal-title":"Acta pathologica, microbiologica, et immunologica Scandinavica. Sect C, Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2018.06.033_b0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.06.033_b0065","doi-asserted-by":"crossref","unstructured":"Hamilton JA, Anderson GP. GM-CSF biology. Growth factors (Chur, Switzerland) 2004;22(4):225\u201331.","DOI":"10.1080\/08977190412331279881"},{"issue":"12","key":"10.1016\/j.vaccine.2018.06.033_b0070","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.4049\/jimmunol.171.12.6846","article-title":"Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils, involvement of the ribosomal p70 S6 kinase signaling pathway","volume":"171","author":"Gomez-Cambronero","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.033_b0075","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1189\/jlb.0809546","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF): a chemoattractive agent for murine leukocytes in vivo","volume":"89","author":"Khajah","year":"2011","journal-title":"J Leukocyte Biol"},{"issue":"11","key":"10.1016\/j.vaccine.2018.06.033_b0080","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.4049\/jimmunol.1201789","article-title":"GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation","volume":"189","author":"Chen","year":"2012","journal-title":"J Immunol (Baltimore, Md.: 1950)"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2018.06.033_b0085","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0264-410X(01)00469-8","article-title":"Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor","volume":"20","author":"Follador","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.033_b0090","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/cmi.2015.64","article-title":"Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice","volume":"13","author":"Wang","year":"2016","journal-title":"Cell Mol Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2018.06.033_b0095","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.vaccine.2015.02.019","article-title":"Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation","volume":"33","author":"Lee","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.033_b0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/eji.200939665","article-title":"Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection","volume":"40","author":"Nambiar","year":"2010","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.06.033_b0105","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01514-17","article-title":"Role of granulocyte-macrophage colony-stimulating factor production by T cells during Mycobacterium tuberculosis infection","volume":"8","author":"Rothchild","year":"2017","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.033_b0110","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/apm.12660","article-title":"Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model","volume":"125","author":"Mahdavi","year":"2017","journal-title":"APMIS: acta pathologica, microbiologica, et immunologica Scandinavica"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2018.06.033_b0115","first-page":"187","article-title":"Vaccine protection in the elderly: are Austrian seniors adequately protected by vaccinations? [Impfschutz im Alter: Sind osterreichische Senioren durch Impfungen ausreichend geschutzt?]","volume":"114","author":"Hainz","year":"2002","journal-title":"Wiener klinische Wochenschrift"},{"key":"10.1016\/j.vaccine.2018.06.033_b0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coi.2014.11.001","article-title":"Reis e Sousa C. Defining dendritic cells","volume":"32","author":"Schraml","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"#cr-split#-10.1016\/j.vaccine.2018.06.033_b0125.1","unstructured":"WHO. Diphtheria - Yemen, Disease outbreak news [Internet] [updated 2017 Dec 22"},{"key":"#cr-split#-10.1016\/j.vaccine.2018.06.033_b0125.2","unstructured":"cited 2018 Mar 13]. Available from: <http:\/\/www.who.int\/csr\/don\/22-december-2017-diphtheria-yemen\/en\/>."},{"issue":"11","key":"10.1016\/j.vaccine.2018.06.033_b0130","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.4049\/jimmunol.169.11.6324","article-title":"GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis","volume":"169","author":"Lu","year":"2002","journal-title":"J Immunol (Baltimore, Md.: 1950)"},{"issue":"10","key":"10.1016\/j.vaccine.2018.06.033_b0135","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.vaccine.2005.09.046","article-title":"A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens","volume":"24","author":"Singh","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2018.06.033_b0140","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1080\/21505594.2017.1321726","article-title":"Biophysical comparison of diphtheria and tetanus toxins with the formaldehyde-detoxified toxoids, the main components of diphtheria and tetanus vaccines","volume":"8","author":"Alsarraf","year":"2017","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.033_b0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20081571","article-title":"The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells","volume":"206","author":"Dienz","year":"2009","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2018.06.033_b0150","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/icb.2012.17","article-title":"IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells","volume":"90","author":"Diehl","year":"2012","journal-title":"Immunol Cell Biol"},{"issue":"11","key":"10.1016\/j.vaccine.2018.06.033_b0155","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","article-title":"Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production","volume":"192","author":"Breitfeld","year":"2000","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.033_b0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.20020026","article-title":"Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation","volume":"196","author":"Diehl","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.06.033_b0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of Effector CD4 T Cell Populations*","volume":"28","author":"Zhu","year":"2010","journal-title":"Ann Rev Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2018.06.033_b0170","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2018.06.033_b0175","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2018.06.033_b0180","doi-asserted-by":"crossref","first-page":"a016873","DOI":"10.1101\/cshperspect.a016873","article-title":"MHC class II antigen presentation by dendritic cells regulated through endosomal sorting","volume":"5","author":"ten Broeke","year":"2013","journal-title":"Cold Spring Harbor Perspect Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:26:40Z","timestamp":1759400800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18308612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":37,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X18308612"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}